Multimodal Therapy Yields Decade-Long Survival in Advanced Drug-Resistant Lung Cancer
A longitudinal study documents nearly ten years of survival in advanced lung adenocarcinoma achieved by combining sequential targeted therapies, anti-angiogenic ...










